Show Me The Evidence and The ROI: Digital Health Investing in 2023 via GSR Ventures
Health Populi
DECEMBER 6, 2022
With valuations of digital health companies expected to decline in 2023, investors in the sector are Missourian in spirit in “Show Me” mode: here, it’s all about the clinical evidence and ROI, according to a survey from GSR Ventures. AI drug discovery and clinical trial technology (each at 27%), and, Interoperability (22%).
Let's personalize your content